Related Articles
Paclitaxel combined with cis-platin as second-line treatment in patients with advanced non-small cell lung cancers refractory to cis-platin.
Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a Phase II study
Survival after cytotoxic chemotherapy in patients with advanced hormone-resistant prostate cancer: A phase II study
Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: A Phase III study
Metastatic renal cancer and patient survival as a criterion of treatment response